The synthetic retinoid ST1926 as a novel therapeutic agent in rhabdomyosarcoma-Reference-Cited by-同舟云学术

The synthetic retinoid ST1926 as a novel therapeutic agent in rhabdomyosarcoma

Published:2015-10-22 Issue:6 Volume:138 Page:1528-1537
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Basma Hussein¹,Ghayad Sandra E.²,Rammal Ghina²,Mancinelli Angelo³,Harajly Mohammad¹,Ghamloush Farah¹,Dweik Loai¹,El-Eit Rabab⁴,Zalzali Hassan¹,Rabeh Wissam¹,Pisano Claudio³,Darwiche Nadine⁵,Saab Raya¹⁴

Affiliation:

1. Children's Cancer Institute, American University of Beirut; Beirut Lebanon

2. Department of Biology; Faculty of Science, EDST, Lebanese University; Beirut Lebanon

3. Medicinal Investigational Research, Biogem Research Institute; Ariano Irpino Italy

4. Department of Anatomy; Cell Biology and Physiology, American University of Beirut; Beirut Lebanon

5. Department of Biochemistry and Molecular Genetics; American University of Beirut; Beirut Lebanon

Funder

Lebanese National Council for Scientific Research (CNRS)

American Lebanese Syrian Associated Charities (ALSAC)

International Outreach Program at St Jude Children's Research Hospital, Memphis, TN

Children's Cancer Center of Lebanon

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference47 articles.

1. Myogenesis and rhabdomyosarcoma the Jekyll and Hyde of skeletal muscle;Saab;Curr Top Dev Biol,2011

2. Childhood nonrhabdomyosarcoma soft tissue sarcomas are not adult-type tumors;Spunt;J Clin Oncol,2006

3. Rhabdomyosarcoma;Stuart;Indian J Pediatr,2004

4. Rhabdomyosarcoma-working out the pathways;Merlino;Oncogene,1999

5. PAX3-FKHR and PAX7-FKHR gene fusions are prognostic indicators in alveolar rhabdomyosarcoma: a report from the children's oncology group;Sorensen;J Clin Oncol,2002

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Synthetic lethality between ATR and POLA1 reveals a potential new target for individualized cancer therapy;Neoplasia;2024-11

2. Novel ST1926 Nanoparticle Drug Formulation Enhances Drug Therapeutic Efficiency in Colorectal Cancer Xenografted Mice;Nanomaterials;2024-08-23

3. Development and Challenges of Synthetic Retinoid Formulations in Cancer;Current Drug Delivery;2023-11

4. The Antitumor Effect of the DNA Polymerase Alpha Inhibitor ST1926 in Glioblastoma: A Proteomics Approach;International Journal of Molecular Sciences;2023-09-14

5. Antitumor activity of novel POLA1-HDAC11 dual inhibitors;European Journal of Medicinal Chemistry;2022-01